Contact James

Speaking Engagements

  

Hear from and meet with the leading figures in biomarker analysis to explore how companies are innovating in biomarker analysis to accelerate timelines and reduce risk in drug development, with in-depth consideration of the latest multiplexed and cytometry tools impacting biomarker research & validation.

01-02 November 2022
  

The gamma delta T therapy industry is currently experiencing a surge in activity, with Adicet Bio, Leucid, Century, Imcheck, IN8bio, Sanofi, and Takeda among the leading companies competing to develop effective treatments for solid tumors. With mounting evidence of clinical efficacy, these companies are investing heavily in research and development

25-27 July 2023